WO2024003711 - PHOSPHOLIPID COMPOSITIONS COMPRISING EPA AND/OR DHA FOR AMELIORATING NEURODEGENERATION AND AGE-RELATED NEURODEGENERATIVE DISORDERS
National phase entry:
Publication Number
WO/2024/003711
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056584
International Filing Date
26.06.2023
Title **
[English]
PHOSPHOLIPID COMPOSITIONS COMPRISING EPA AND/OR DHA FOR AMELIORATING NEURODEGENERATION AND AGE-RELATED NEURODEGENERATIVE DISORDERS
[French]
COMPOSITIONS DE PHOSPHOLIPIDES COMPRENANT DE L’EPA ET/OU DU DHA DESTINÉES À AMÉLIORER LA NEURODÉGÉNÉRESCENCE ET LES TROUBLES NEURODÉGÉNÉRATIFS LIÉS À L’ÂGE
Applicants **
AKER BIOMARINE HUMAN INGREDIENTS AS
Inventors
JOHNSEN, Line
Priority Data
2209414.8
27.06.2022
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3343 | |
| EPO | Filing, Examination, Granting | 28406 | |
| Japan | Filing, Examination, Granting | 3276 | |
| South Korea | Filing, Examination, Granting | 4289 | |
| USA | Filing, Examination, Granting | 10940 |
Total:
50,254
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to compositions comprising marine derived phospholipids for ameliorating at least one aging hallmark selected from the group consisting of genomic instability, telomere shortening, an epigenetic alteration, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and deregulated nutrient sensing and intercellular communication.[French]
La présente invention porte sur des compositions comprenant des phospholipides d’origine marine destinées à améliorer au moins un marqueur de vieillissement sélectionné parmi le groupe constitué de l’instabilité génomique, du raccourcissement de télomères, d’une altération épigénétique, de la perte de protéostase, de la détection dérégulée des nutriments, du dysfonctionnement mitochondrial, de la sénescence cellulaire, de l’épuisement des cellules souches, et de la détection dérégulée des nutriments et de la communication intercellulaire.